Chronic kidney disease and mortality and morbidity among patients with established cardiovascular disease: A West of Ireland community-based cohort study

Nephrology Dialysis Transplantation

Volumn 22, Issue 9, 2007, Pages 2586-2594

  Glynn, Liam G ^a   Reddan, Donal ^b   Newell, John ^a   Hinde, John ^a   Buckley, Brian ^a   Murphy, Andrew W ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Coronary disease; Kidney; Mortality; Primary care

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; COMMUNITY LIVING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENERAL PRACTICE; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HUMAN; IRELAND; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOMES RESEARCH; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RANDOM SAMPLE; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STROKE; SURVIVAL RATE;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; CREATININE; ENDPOINT DETERMINATION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IRELAND; KAPLAN-MEIERS ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; PROPORTIONAL HAZARDS MODELS; RESIDENCE CHARACTERISTICS; TREATMENT OUTCOME;

EID: 34548460831     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm222     Document Type: Article

References (43)

1. Anavekar NS, McMurray JJV, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295
2. Ezekowitz J, McAlister FA, Humphries KH et al. The association among renal insufficiency, pharmacotherapy and outcomes in 6427 patients with heart failure and coronary artery disease. Journal of the American College of Cardiology 2004; 44: 1587-1592
3. McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ. Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 2002; 144: 226-232
4. Levey AS. Measurement of renal function in chronic renal disease. Kidney Int 1990; 38: 167-184
5. Swedko PJ, Clark HD, Paramsothy K, Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003; 163: 356-360
6. Smith H. Diseases of the kidney and urinary tract. In: The Kidney: Structure and Function in health and disease. Oxford University Press, New York: 1951; 836-887
7. Muntner P, He J, Hamm L, Loria C, Whelton PK. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 2002; 13: 745-753
8. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C-Y. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 2004; 351: 1296-1305
9. Tonelli M, Jose P, Curhan G et al. Proteinuria, impaired kidney function and adverse outcomes in people with coronary disease: Analysis of a previously conducted randomised trial. Br Med J 2006; 332: 1426
10. Wright RS, Reeder GS, Herzog CA et al. Acute myocardial infarction and renal dysfunction: A high-risk combination. Ann Intern Med 2002; 137: 563-570
11. Al Suwaidi J, Reddan DN, William K et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 2002; 106: 974-980
12. Hemmelgarn BR, Southern DA, Humphries KH et al. Refined characterization of the association between kidney function and mortality in patients undergoing cardiac catheterization. Eur Heart J 2006; ehi846
13. Henry RMA, Kamp O, Kostense PJ et al. Mild renal insufficiency is associated with increased left ventricular mass in men, but not in women: An arterial stiffness-relatedTphenomenon: the Hoorn study. Kidney Int 2005; 68: 673-679
14. BMA. Quality and outcomes framework guidance: Summary of indicators - clinical domain. BMA, London: 2006; http://www.bma.org.uk/ap.nsf/Content/ qoft06~summchnical#ChronicKidneyDisease
15. Levey AS, Coresh J, Balk E et al. National Kidney Foundation Practice Guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
16. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke. Stroke 1997; 28: 557-563
17. Culleton BF, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56: 2214-2219
18. Shulman NB, Ford CE, Hall WD et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13 [5 Suppl]: I80-I93
19. Department of Health, and Children. Building healthier hearts: National cardiovascular health strategy. Stationery Office, Dublin: 1999;
20. Reddan DN. Therapy for cardiovascular disease in patients with chronic kidney disease: Appropriate caution or the absence of data. Am Heart J 2002; 144: 206-207
21. Byrne M, Murphy AW, Walsh J. Secondary prevention of coronary heart disease: Patients' beliefs and health related behaviour. J Psychosomatic Res 2005; 58: 403-415
22. Byrne M, Murphy AW, Walsh JC, Shryane E, McGroarty M, Kelleher CC. A cross-sectional study of secondary cardiac care in general practice: impact of personal and practice characteristics. Fam Pract 2006; 23: 295-302
23. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
24. Murchie P, Campbell NC, Ritchie LD, Simpson JA, Thain J. Secondary prevention clinics for coronary heart disease: Four-year follow-up of a randomised controlled trial in primary care. Br Med J 2003; 326: 84
25. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 [2 Suppl 1]: S1-S266
26. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression modelling of time to event data. Wiley Inter-Science, New York: 1999;
27. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 2003; 42: 1050-1065
28. McCullough PA, Soman SS, Shah SS et al. Risks associated with renal dysfunction in patients in the coronary care unit. J Am Coll Cardiol 2000; 36: 679-684
29. Shlipak MG HP, Noguchi H, Chertow GK, Browner WS, McClellan MB. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med 2002; 137: 555-562
30. Anandarajah S, Tai T, de Lusignan S et al. The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): A manual review of 500 medical records. Nephrol Dial Transplant 2005; 20: 2089-2096
31. Perazella MA, Khan S. Increased mortality in chronic kidney disease: A call to action. [Review]. American Journal of the Medical Sciences 2006; 331: 150-153
32. de Lusignan S, Chan T, Stevens P et al. Identifying patients with chronic kidney disease from general practice computer records. Fam Pract 2005; 22: 234-241
33. Shlipak MG, Fried LF, Crump C et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 2003; 107: 87-92
34. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of non-traditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med 2004; 140: 9-17
35. Hsu C-y, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol 2002; 13: 504-510
36. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients: A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 39: 695-701
37. Wanner C, Krane V, Marz W et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
38. Singh AK, Szczech L, Tang KL et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 2006; 355: 2085-2098
39. Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345: 851-860
40. Brenner BM, Cooper ME, de Zeeuw D et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy 10.1056/NEJMoa011161. N Engl J Med 2001; 345: 861-869
41. Traynor J, Mactier R, Geddes CC, Fox JG. How to measure renal function in clinical practice. Br Med J 2006; 333: 733-737
42. Mant J, McManus RJ, Hare R, Mayer P. Identification of stroke in the community: A comparison of three methods. Br J Gen Pract 2003; 53: 520-524
43. U.S. Renal Data System: USRDS 2005 Annual Data Report: Atlas of end-stage renal disease in the United States, National Institutes of Health: National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2005